Evidence map›Paper›PMID 36362386›Full record

ArticleInternational journal of molecular sciences2022

Serum Level of MMP-3 and MMP-9 in Patients with Diabetes Mellitus Type 2 Infected with Epstein-Barr Virus.

Ewa Stępień, Jakub Dworzański, Anna Dworzańska, Bartłomiej Drop, Małgorzata Polz-Dacewicz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ewa StępieńDepartment of Virology with SARS Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-9024-8602
Jakub DworzańskiMasovian Specialist Hospital, 26-617 Radom, Poland.
Anna DworzańskaMasovian Specialist Hospital, 26-617 Radom, Poland.
Bartłomiej DropDepartment of Computer Science and Medical Statistics with the e-Health Laboratory, 20-090 Lublin, Poland.
Małgorzata Polz-DacewiczDepartment of Virology with SARS Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-3222-184X
Medical University of Lublin · PLRadom College · PL

Funding

Medical University of Lublin DS233
6 · The paper itself

Abstract

Diabetes mellitus type 2 (DM2) has recently become one of the most important health problems in the world. Patients with DM2 with long-term glycaemia are more likely to become infected than the healthy population. Matrix metalloproteinases (MMPs) play a key role in tissue remodeling during various physiological processes. However, it has been reported that certain MMPs are overexpressed during the development of various human diseases. In this study, we analyzed the levels of MMP-3 and MMP-9 in the serum of DM2 patients with and without Epstein-Barr virus (EBV) infection. The study included 115 patients with DM2 hospitalized in the Internal Ward of the Masovian Specialist Hospital in Radom, Poland, who were divided into two groups: EBV-positive and EBV-negative. The levels of MMP-3 and MMP-9 were tested in the serum of patients using the ELISA method, while the presence of EBV in saliva was tested by polymerase chain reaction (PCR). The presented studies showed a significant difference in the concentration of both MMPs in diabetic patients additionally infected with EBV compared to the group of non-infected individuals. It seems that MMPs may be useful biomarkers in the diagnosis, prognosis, and monitoring of diabetes associated with EBV infection.

Indexed as

Diabetes Mellitus, Type 2Epstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansMatrix Metalloproteinase 3Matrix Metalloproteinase 9Matrix Metalloproteinase 3Matrix Metalloproteinase 9diabetes mellitus type 2EBVMMP-3MMP-9

Identifiers

PMID36362386
PMCPMC9656098
OpenAlexW4308581128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.